Related Experiment Video
Updated: Feb 11, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
Initial Right Ventricular Dysfunction Severity Identifies Severe Peripartum Cardiomyopathy Phenotype With Worse Early
Andrew Peters1, Mara Caroline1, Huaqing Zhao1
1Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
Insights
Moderate-to-severe right ventricular dysfunction (RVD) at diagnosis independently predicts adverse outcomes in peripartum cardiomyopathy (PPCM). This finding aids in identifying high-risk patients for earlier intervention and advanced therapies.
Area of Science:
- Cardiology
- Cardiovascular Diseases
- Heart Failure
Background:
- Peripartum cardiomyopathy (PPCM) presents with variable patient outcomes.
- The impact of initial left versus right ventricular dysfunction severity on PPCM prognosis remains unclear.
Purpose of the Study:
- To investigate the association between the severity of left or right ventricular dysfunction (RVD) at PPCM diagnosis and adverse patient outcomes.
- To determine if RVD severity independently predicts adverse outcomes in PPCM patients.
Main Methods:
- A retrospective cohort study included 53 patients diagnosed with PPCM.
- Kaplan-Meier curves and Cox proportional hazards models were used to analyze event-free survival.
- Key factors analyzed included left ventricular ejection fraction <30%, LV end-diastolic diameter ≥60 mm, and moderate-to-severe RVD at diagnosis.
Main Results:
- The primary outcome (LVAD implantation, cardiac transplantation, or death) occurred in 32% of patients.
- Moderate-to-severe RVD at diagnosis was present in 11 patients who experienced the primary outcome.
- While initial LV ejection fraction <30% and moderate-to-severe RVD were associated with adverse outcomes in univariable analysis, only moderate-to-severe RVD remained an independent predictor in multivariable analysis (HR, 3.21 [1.13–9.10]).
Conclusions:
- Initial moderate-to-severe right ventricular dysfunction (RVD) signifies a more severe PPCM phenotype.
- Moderate-to-severe RVD at diagnosis is independently associated with increased risk of adverse outcomes, both within and beyond the first year.
- Identifying patients with moderate-to-severe RVD may facilitate earlier consideration of advanced heart replacement therapies.
Background:
Outcomes in peripartum cardiomyopathy (PPCM) vary. We sought to determine whether severity of left or right ventricular dysfunction (RVD) at PPCM diagnosis differentially associates with adverse outcomes.
Methods And Results:
We conducted a single-center retrospective cohort study of 53 patients with PPCM. The primary outcome was a composite of left ventricular assist device implantation, cardiac transplantation, or death. We used Kaplan-Meier curves to examine event-free survival and Cox proportional hazards models to examine associations of left ventricular (LV) ejection fraction <30%, LV end-diastolic diameter ≥60 mm, and moderate-to-severe RVD at PPCM diagnosis with the primary outcome. Median (interquartile range) follow-up time was 3.6 (1.4-7.3) years. Seventeen patients (32%) experienced the primary outcome, of whom 11 had moderate-to-severe RVD at time of PPCM diagnosis. Overall event-free survival differed by initial RVD severity and LV ejection fraction <30%, but not by LV end-diastolic diameter ≥60 mm. In univariable analyses, LV ejection fraction <30% and moderate-to-severe RVD were associated with the outcome (hazard ratios [95% confidence intervals] of 4.85 [1.11-21.3] and 4.26 [1.47-11.6], respectively). In a multivariable model with LV ejection fraction <30%, LV end-diastolic diameter ≥60 mm, and moderate-to-severe RVD, only moderate-to-severe RVD was independently associated with the outcome (hazard ratio [95% confidence interval], 3.21 [1.13-9.10]). Although most outcomes occurred within the first year, nearly a third occurred years after PPCM diagnosis.
Conclusions:
Initial moderate-to-severe RVD is associated with a more advanced cardiomyopathy phenotype and increased risk of adverse outcomes in PPCM, within and beyond the first year of diagnosis. By identifying a worse PPCM phenotype, initial moderate-to-severe RVD may prompt earlier consideration of advanced heart replacement therapies.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Cardiomyopathy V: Interprofessional Care

